Jane Meisel

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial”.

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma

European Journal of Nuclear Medicine and Molecular Imaging(2024)10.1007/s00259-024-06830-7

N/A

0.410DataRank · unranked

8 citations

Ismaheel O. Lawal, Saima Muzahir, Sarah Friend, Manali Bhave, Jane Meisel +8 more

Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial

JCO Oncology Practice(2024)10.1200/op.24.00031

N/A

0.208DataRank · unranked

3 citations

Samuel Hernández, Sara Arshad, Kristina Byers, Jane Meisel, Gelareh Sadigh +4 more

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

The Breast(2025)10.1016/j.breast.2025.104547

N/A

0.165DataRank · unranked

2 citations

Samuel M. Niman, Ann H. Partridge, Daniela Diego, Roswitha Kammler, Monica Ruggeri +31 more

Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108145

N/A

0.104DataRank · unranked

1 citations

Fenghai Duan, Ilana F. Gareen, Judy Hancock, JoRean D. Sicks, Maryanne Thangarajah +8 more

Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.022

N/A

0DataRank · unranked

11 citations

Beryl Manning‐Geist, Andrea Knežević, Luxue Deng, Maria Bromberg, Samuel A. Funt +13 more

A Tale of 3 Tracers

Clinical Nuclear Medicine(2022)10.1097/rlu.0000000000004385

N/A

0DataRank · unranked

3 citations

Omotayo A. Adediran, Saima Muzahir, Sarah Friend, Manali Ajay Bhave, Jane Meisel +10 more

The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy

Clinical Breast Cancer(2020)10.1016/j.clbc.2020.05.007

N/A

0DataRank · unranked

11 citations

D. Zaenger, Jeffrey M. Switchencko, Jolinta Y. Lin, Mustafa Abugideiri, Cletus A. Arciero +8 more